Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641489-25-000026
Filing Date
2025-05-15
Accepted
2025-05-15 16:07:07
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-20250331.htm   iXBRL 10-Q 754896
2 EX-31.1 vtvt-20250331xexx311.htm EX-31.1 10140
3 EX-31.2 vtvt-20250331xexx312.htm EX-31.2 10361
4 EX-32.1 vtvt-20250331xexx321.htm EX-32.1 4944
5 EX-32.2 vtvt-20250331xexx322.htm EX-32.2 4919
11 GRAPHIC vtvt-20250331_g1.jpg GRAPHIC 148566
  Complete submission text file 0001641489-25-000026.txt   5552673

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20250331.xsd EX-101.SCH 41109
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20250331_cal.xml EX-101.CAL 43355
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20250331_def.xml EX-101.DEF 268314
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20250331_lab.xml EX-101.LAB 527423
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20250331_pre.xml EX-101.PRE 389266
70 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20250331_htm.xml XML 552740
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 25952852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)